A botanical and pharmacological description of petasites species

• Authors: Jerzy Tys , Aleksandra Szopa , Justyna Lalak , Mariola Chmielewska , Anna Serefko , Ewa Poleszak
• Languages of publication: EN

Abstracts

EN

The objective of this review was to evaluate the botanical and pharmacological description of Petasites species. Petasides (butterbur) as a perennial shrub which was found in Europe and also in a parts of Asia and North America, has been widely used medicinally for centuries. At present, the main phytopharmacology uses for Petasides extracts are for prophylactic treatment of migraines, as well as an antispasmodic agent for bronchial asthma and pertussis. Furthermore, it has been used effectively in preventing gastric ulcers, and in urinary tract spasms and treating patients with irritable bladder. But still, there is a need for more studies on the potential applications of butterbur extract in medicine.

Keywords

EN

butterbur; pharmacological studies; clinical trials; migraine; asthma; gastroenteritis

• Publisher: De Gruyter Open
• Journal: Current Issues in Pharmacy and Medical Sciences
• Year: 2015
• Volume: 28
• Issue: 3
• Pages: 151-154

Dates

published

1 - 9 - 2015

accepted

21 - 7 - 2015

online

26 - 11 - 2015

received

3 - 6 - 2015

Contributors

author

Jerzy Tys

• The Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences, Doswiadczalna 4, 20-290 Lublin, Poland

author

Aleksandra Szopa

• Chair and Department of Applied Pharmacy, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland

author

Justyna Lalak

• The Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences, Doswiadczalna 4, 20-290 Lublin, Poland

author

Mariola Chmielewska

• The Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences, Doswiadczalna 4, 20-290 Lublin, Poland

author

Anna Serefko

• Chair and Department of Applied Pharmacy, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland

author

Ewa Poleszak

• Chair and Department of Applied Pharmacy, Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland

References

• 1. Agostia R. et al.: Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: A systematic review. Phytomed., 13, 743, 2006.[Crossref]
• 2. Aydin A.A. et al.: The medical plant butterbur (Petasites): analytical and physiological (re)view. J. Pharm. Biomed. Anal., 75, 220, 2013.[WoS][Crossref]
• 3. Aydin A.A., Letzel T.: Simultaneous investigation of sesquiterpenes, pyrrolizidine alkaloids and N-oxides in Butterbur (Petasites hybridus) with an offline 2D-combination of HPLC-UVandLCMMI- ToF-MS. J. Pharm. Biomed. Anal., 85, 74, 2013.[Crossref]
• 4. Blumenthal M., editor (1998). The Complete German Commission E Monographs. Austin, TX: American Botanical Council.
• 5. Broda B., Mowszowicz J., editors (2000). Przewodnik do oznaczania roślin leczniczych, trujących i użytkowych. Warszawa: Polskie Wydawnictwo Lekarskie PZWL.
• 6. Brune K. et al.: Europaeische Patentanmeldung 0-281-656 vom. 19.09.88. Europaeisches Patentamt: Patentblatt 88/37 (1988).
• 7. Brune K., Bickel D., Peskar B.A.: Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis. Planta. Med., 59, 494, 1993.[Crossref]
• 8. Bucher, K.: Uber ein antispastisches Prinzip in Petasites officinalis Moench. Arch. Exp. Path. Pharmacol., 213, 69, 1950.
• 9. Bull L.B., Dick A.T., McKenzie J.S.: The acute toxic effects of heliotrine and lasio- carpine and their n-oxides, on the rat. J. Path. Bact., 75, 17, 1958.[Crossref]
• 10. Bull L.B., Dick A.T.: The chronic pathological effects on the liver of the rat of the pyrrolizidine alkaloids heliotrine, lasiocarpine and their n-oxides. J. Path. Bact., 78, 483, 1959.[Crossref]
• 11. Cherniawsky D.M., Bayer R.J.: Systematics of North American Petasites (Asteraceae: Senecioneae). I. Morphometric analyses. Can. J. Bot., 76, 23, 1998.
• 12. Cherniawsky D.M., Bayer R.J.: Systematics of North American Petasites (Asteraceae: Senecioneae). III. A taxonomic revision. Can. J. Bot., 76, 2061, 1998.
• 13. Debrunner B., Meier B.: Petasites hybridus: a tool for interdisciplinary research in phytotherapy. Pharm. Acta. Helv., 72(6), 359, 1998.[Crossref]
• 14. Eaton J.: Butterbur, herbal help for migraine. Nat. Pharm., 2(1), 23, 1998.
• 15. Fiebich B.L. et al.: Petasites hybridus extracts in vitro inhibit COX-2 and PGE2 release by direct interaction with the enzyme and by preventing p42/44 MAP kinase activation in rat primary microglial cells. Planta. Med., 71, 12, 2005.
• 16. Grossman W., Schmidramsl H.: An extract of Petasites hybridus is effective in the prophylaxis of migraine. Altern. Med. Rev., 6, 303, 2001.
• 17. Grossmann W.M., Schmidramsl H.: An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int. J. Clin. Pharmacol. Ther., 38, 430, 2000.[Crossref]
• 18. Jennings N.L., editor (2008). Coastal Beauty: Wildflowers and Flowering Shrubs of Coastal British Columbia and Vancouver Island. Calgary: Rocky Mountain Books.
• 19. Ko W.C. et al.: Mechanisms of relaxant-action of S-petasin and S-isopetasin, sesquiterpenes of Petasites formosanus in isolated guinea pig trachea. Planta. Med., 67, 224, 2001.
• 20. Kwaśniewska J.: Podbiał (Tussilago L.) a lepiężnik (Petasites Mill.). Ziel. Biul. Inf., 10(1), 11, 1958.
• 21. Lee K.P. et al.: Therapeutic Effects of S-Petasin on Disease Models of Asthma and Peritonitis. Biomol. Ther., 23(1), 45, 2015.[Crossref][WoS]
• 22. Lipton R.B. et al.: Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurol., 63, 2240, 2004.[Crossref]
• 23. Mauskop A., Grossmann W.M., Schmidramsl H.: Petasites hybridus (butterbur root) extract is effective in the prophylaxis of migraines. Results of a randomized, double-blind trial. J. Head. Face. Pain., 40, 4, 2000.
• 24. Mauskop A.: Petasites hybridus: an ancient medicinal plant is an effective prophylactic treatment for migraine. Townsend. Lett., 202, 104, 2000.
• 25. Ożarowski M., Przystanowicz J., Adamczak A.: Phytochemical, pharmacological and clinical studies of Petasites hybridus (L.) P. Gaertn., B. Mey. & Scherb. A review. Herb. Pol., 59(4), 108, 2013.
• 26. Preston C.D., Pearman D.A., Dines T.D., editors (2002). New Atlas of the British and Irish Flora. Oxford: Oxford University Press.
• 27. Rutkowski L., editor (1998). Klucz do oznaczania roślin naczyniowych Polski niżowej. Warszawa: Wydawnictwo Naukowe PWN.
• 28. Ryan R.E.: A new preparation for the interval treatment of migraine. Headache, 11, 6, 1971.[Crossref]
• 29. Shih C.H. et al.: S-petasin, the main sesquiterpene of Petasites formosanus, inhibits phosphodiesterase activity and suppresses ovalbumin-induced airway hyperresponsiveness. Evid. Bas. Complem. Alternat. Med., 4, 132, 2011.
• 30. Siniatchkin M., Gerber W.D., Vein A.: Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo controlled study. Funct. Neurol., 13, 47, 1998.
• 31. Soyka D., Östreich W.: Flunarizine vs. propanolol in the interval treatment of migraine: A multi-center, double-blind study from practicing general medical doctors and internists. Nervenheilkunde, 19, 45, 1990.
• 32. Szafer W., Kulczyński S., Pawłowski B., editors (1986). Rośliny Polskie vol. II. Warszawa: Wydawnictwo Naukowe PWN.
• 33. Tan K. et al.: On a new Petasites species from the southern Pindos (Greece). Phytol. Balcan., 16(2), 243, 2010.
• 34. Tfelt P. et al.: Timonol vs propanolol in common migraine prophylaxis. A double-blind multi-center trial. Acta. Neuol. Scand., 69, 1, 1984.[Crossref]
• 35. Thomet O.A.R. et al.: Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. Clin. Exp. Allergy., 31, 1310, 2001.[Crossref]
• 36. Toman J.: A taxonomic survey of the genera Petasites and Endocellion. Folia. Geobot. Phytotax., 7, 381, 1972.[Crossref]
• 37. Uziębło A.K. (2004). Subalpine populations of Petasites kablikianus Tausch ex. Bercht. in the Babia Góra and in the Karkonosze National Parks. In: Geoekologické problémy Krkonoš. Štursa J., Mazurski K.R., Palucki A., Potocka J. (editors). Opera Corcontica; p. 135.
• 38. Uziębło A.K.: Petasites kablikianus Tausch ex Berchtold as a pioneer species and its abilities to colonise initial habitats. Pr. N. U. Ś., 2886, 1, 2011.
• 39. Wang Y.L. et al.: Bakkenolides from Petasites tricholobs and their neuroprotective effects related to antioxidant activities. Planta. Med.,75, 230, 2009.[Crossref]
• 40. Wang Y.L., Guo M., Wang Y.: Quality evaluation of Petasites tricholobus through simultaneous determination of four bioactive bakkenolides by LC. Chromatograph., 70, 1367, 2009.[Crossref]
• 41. Wang, G.J. et al.: Ca2+ channel blocking effect of iso-S-petasin in rat aortic smooth muscle cells. Eur. J. Pharmacol., 445, 239, 2002.
• 42. Weerasuriya K., Patel L., Turner P.: Beta-adreno-receptor blockade and migraine. Cephalalg., 2, 33, 1982.[Crossref]
• 43. Wildi E. et al.: Quantitative analysis of petasin and pyrrolizidine alkaloids in leaves and rhizomes of in situ grown Petasites hybridus plants. Plant. Med. 64, 264, 1998.[Crossref]
• 44. Wu S.N., Chen H., Lin Y.L.: The mechanism of inhibitory actions of S-petasin, a sesquiterpene of Petasites formosanus, on L-type calcium current in NG108-15 neuronal cells. Planta. Med., 69, 118, 2002.
• 45. Yuzuri I., Wataru N.: New Japanese Butterbur Variety with High Yield and High Quality. Breed. Sci., 57(3), 249, 2007.[WoS][Crossref]
• 46. Zając A., Zając M., editors (2001). Atlas rozmieszczenia roślin naczyniowych w Polsce. Kraków: Pracownia Chorologii Komputerowej Instytutu Botaniki Uniwersytetu Jagiellońskiego.
• 47. Zioło G, Samochowiec L.: Study on clinical properties and mechanism of action of Petasites in bronchial asthma and chronic obstructive bronchitis. Pharmaceut. Act. Helv., 72, 359, 1998.

Identifiers

DOI

10.1515/cipms-2015-0062